Carol A Aghajanian MD

PubMed

• Very low-carbohydrate ketogenic diet in treatment-naïve women with endometrial cancer and overweight: a randomized feasibility study.
  Ezequiel Dantas, Katie C Hootman, Jenna Moyer, Morgan Tomberlin, Katherine Curran
  Nature Communications. 2026-05-27
• Radiation Quality and Workflow in NRG GY017: Anti PD-L1 (Atezolizumab) as an immune primer or concurrently with RT for node positive locally advanced cervical cancer.
  Jyoti Mayadev, Wei Deng, Hayeon Kim, Ying Xiao, Junzo P Chino
  International Journal of Radiation Oncology, Biology, Physics. 2026-05-24
• Prognostic comparison of the FIGO 2009 and 2023 endometrial cancer staging systems: a large, single-institution retrospective cohort study.
  Tiffany Y Sia, Qin Zhou, Sean Devlin, Alexia Iasonos, Sana Hatoum
  International Journal of Gynecological Cancer. 2026-04-25

Journal Articles

• A Phase 1 Dose-Escalation Study of Intraperitoneal Cisplatin, intravenous/intraperitoneal Paclitaxel, Bevacizumab, and Olaparib for Newly Diagnosed Ovarian Cancer  
  Karen A Cadoo, Roisin E O'Cearbhaill, Dmitriy Zamarin, Paul J Sabbatini, William P Tew, Carol Aghajanian, Jason A Konner, Gynecologic Oncology
• Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer  
  Kathleen Moore, Paul DiSilvestro, Carol Aghajanian, The New England Journal of Medicine

Lectures

• Targeted Agents: Finding the Mark 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
• Evaluation of rucaparib in platinum-sensitive recurrent ovarian carcinoma (rOC) in patients (pts) with or without residual bulky disease at baseline in the ARIEL3 study. 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
• Scientific and Clinical Update in Gynecologic Oncology 
  Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania - 5/3/2013